PeptideDB

Verapamil EP Impurity C hydrochloride (NSC-609249 hydrochloride) 51012-67-0

Verapamil EP Impurity C hydrochloride (NSC-609249 hydrochloride) 51012-67-0

CAS No.: 51012-67-0

NSC-609249HCl is an impurity in verapamil. Verapamil is a calcium channel blocker and a potent oral first-generation inh
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

NSC-609249 HCl is an impurity in verapamil. Verapamil is a calcium channel blocker and a potent oral first-generation inhibitor of p-glycoprotein (P-gp).

Physicochemical Properties


Molecular Formula C12H20CLNO2
Molecular Weight 245.75
Exact Mass 245.118
CAS # 51012-67-0
PubChem CID 355505
Appearance Off-white to light yellow solid powder
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 5
Heavy Atom Count 16
Complexity 173
Defined Atom Stereocenter Count 0
InChi Key YKFNIODBMIRAKM-UHFFFAOYSA-N
InChi Code

InChI=1S/C12H19NO2.ClH/c1-13(2)8-7-10-5-6-11(14-3)12(9-10)15-4;/h5-6,9H,7-8H2,1-4H3;1H
Chemical Name

2-(3,4-dimethoxyphenyl)-N,N-dimethylethanamine;hydrochloride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Verapamil as a culprit of palbociclib toxicity. J Oncol Pharm Pract. 2019 Apr;25(3):743-746.

[2]. Krikler DM. Verapamil in arrhythmia. Br J Clin Pharmacol. 1986;21 Suppl 2:183S-189S.


Solubility Data


Solubility (In Vitro) DMSO: 62.5 mg/mL (254.32 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (8.46 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (8.46 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (8.46 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.0692 mL 20.3459 mL 40.6918 mL
5 mM 0.8138 mL 4.0692 mL 8.1384 mL
10 mM 0.4069 mL 2.0346 mL 4.0692 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.